(Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations

[1]  H. Kobori,et al.  High glucose augments angiotensinogen in human renal proximal tubular cells through hepatocyte nuclear factor-5 , 2017, PloS one.

[2]  J. Sheu,et al.  Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling , 2017, Scientific Reports.

[3]  T. Tamiya,et al.  (Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway. , 2017, Journal of neurosurgery.

[4]  Shin-E Wang,et al.  Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis , 2016, Oncotarget.

[5]  Y. Bian,et al.  Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis , 2016, OncoTargets and therapy.

[6]  S. Yachida,et al.  (Pro)renin receptor is crucial for Wnt/β-catenin-dependent genesis of pancreatic ductal adenocarcinoma , 2015, Scientific Reports.

[7]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[8]  Baocun Sun,et al.  Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression , 2014, Journal of experimental & clinical cancer research : CR.

[9]  Takashi Suzuki,et al.  Expression of (pro)renin receptor in breast cancers and its effect on cancercell proliferation. , 2014, Biomedical research.

[10]  J. Li,et al.  Wnt modulates MCL1 to control cell survival in triple negative breast cancer , 2014, BMC Cancer.

[11]  Myung Ah Lee,et al.  Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer , 2014, BMC Cancer.

[12]  Kazuhiro Takahashi,et al.  Increased expression of (pro)renin receptor in aldosterone-producing adenomas , 2013, Peptides.

[13]  Giusi Moffa,et al.  Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells , 2013, Nature Communications.

[14]  Mira Ayadi,et al.  Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value , 2013, PLoS medicine.

[15]  P. Stawowy,et al.  The (pro)renin receptor ((P)RR) can act as a repressor of Wnt signalling. , 2012, Biochemical pharmacology.

[16]  Fen Nie,et al.  The E3 Ubiquitin Ligase ITCH Negatively Regulates Canonical Wnt Signaling by Targeting Dishevelled Protein , 2012, Molecular and Cellular Biology.

[17]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[18]  E. Lalli,et al.  The Wnt/beta-catenin pathway in adrenocortical development and cancer , 2011, Molecular and Cellular Endocrinology.

[19]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[20]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[21]  D. Richel,et al.  Targeting Wnt Signaling in Colon Cancer Stem Cells , 2010, Clinical Cancer Research.

[22]  O. Kallioniemi,et al.  FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells. , 2010, Cancer research.

[23]  Kazuhiro Takahashi,et al.  Expression of (pro)renin receptor in human kidneys with end-stage kidney disease due to diabetic nephropathy , 2010, Peptides.

[24]  A. Balmain,et al.  Guidelines for the welfare and use of animals in cancer research , 2010, British Journal of Cancer.

[25]  B. Nordlinger,et al.  Colorectal cancer , 2010, The Lancet.

[26]  G. Bu,et al.  LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy , 2010, Proceedings of the National Academy of Sciences.

[27]  C. Cruciat,et al.  Requirement of Prorenin Receptor and Vacuolar H+-ATPase–Mediated Acidification for Wnt Signaling , 2010, Science.

[28]  K. Asayama,et al.  Gene expression of (pro)renin receptor is upregulated in hearts and kidneys of rats with congestive heart failure , 2009, Peptides.

[29]  W. Birchmeier,et al.  Wnt signalling and its impact on development and cancer , 2008, Nature Reviews Cancer.

[30]  R. Nusse,et al.  Wnts as ligands: processing, secretion and reception , 2006, Oncogene.

[31]  T. Asahara,et al.  Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. , 2006, Cancer research.

[32]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[33]  Yonghe Li,et al.  LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering β-catenin subcellular distribution , 2004, Oncogene.

[34]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[35]  Louise R Howe,et al.  Wnt Signaling and Breast Cancer , 2004, Cancer biology & therapy.

[36]  G. Nguyen,et al.  Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. , 2002, The Journal of clinical investigation.

[37]  J. Youngson,et al.  Comparison of different scoring systems for immunohistochemical staining. , 1999, Journal of clinical pathology.

[38]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[39]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[40]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.